These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 36576731)
21. ARID1A loss activates MAPK signaling via DUSP4 downregulation. Mandal J; Yu ZC; Shih IM; Wang TL J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of human DUSP4 gene by cancer-related transcription factors. Varela T; Conceição N; Laizé V; Cancela ML J Cell Biochem; 2021 Oct; 122(10):1556-1566. PubMed ID: 34254709 [TBL] [Abstract][Full Text] [Related]
23. Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer. Hanna A; Nixon MJ; Estrada MV; Sanchez V; Sheng Q; Opalenik SR; Toren AL; Bauer J; Owens P; Mason FM; Cook RS; Sanders ME; Arteaga CL; Balko JM Breast Cancer Res; 2022 Jul; 24(1):51. PubMed ID: 35850776 [TBL] [Abstract][Full Text] [Related]
24. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner. Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568 [TBL] [Abstract][Full Text] [Related]
25. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. Wu X; Zhu M; Fletcher JA; Giobbie-Hurder A; Hodi FS PLoS One; 2012; 7(1):e29622. PubMed ID: 22253748 [TBL] [Abstract][Full Text] [Related]
26. DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway. Al-Mutairi MS; Habashy HO Molecules; 2022 Sep; 27(19):. PubMed ID: 36234680 [TBL] [Abstract][Full Text] [Related]
27. Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4. Han J; Ye S; Chen J; Wang K; Jin J; Zeng Z; Xue S Biochemistry (Mosc); 2021 Dec; 86(12):1624-1634. PubMed ID: 34937541 [TBL] [Abstract][Full Text] [Related]
28. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas. Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975 [TBL] [Abstract][Full Text] [Related]
35. DUSP4 inhibits autophagic cell death in PTC by inhibiting JNK-BCL2-Beclin1 signaling. He H; Du Z; Lin J; Wu W; Yu Y Biochem Cell Biol; 2021 Oct; 99(5):554-561. PubMed ID: 33621155 [TBL] [Abstract][Full Text] [Related]
36. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4. Xu X; Gao F; Wang J; Tao L; Ye J; Ding L; Ji W; Chen X Cancer Biol Ther; 2018 May; 19(5):427-435. PubMed ID: 29509059 [TBL] [Abstract][Full Text] [Related]
37. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma. Mergener S; Siveke JT; Peña-Llopis S Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614 [TBL] [Abstract][Full Text] [Related]
38. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295 [TBL] [Abstract][Full Text] [Related]
39. Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and after Neoadjuvant Chemotherapy in Breast Cancer. Prihantono P; Usman AN; Binekada C; Hatta M; Islam AA Asian Pac J Cancer Prev; 2019 Apr; 20(4):1051-1055. PubMed ID: 31030473 [TBL] [Abstract][Full Text] [Related]
40. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells. Musi E; Ambrosini G; de Stanchina E; Schwartz GK Mol Cancer Ther; 2014 May; 13(5):1044-53. PubMed ID: 24563540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]